Project Details
| Status | Active |
|---|---|
| Effective start/end date | 1/05/23 → 30/04/27 |
Funding
- Boehringer Ingelheim International GmbH: £457,058.04
Copy of Immunotherapeutic enhancement through inhibition of alternative splicing
- Myant, Kevin (Principal Investigator)